Emcure Pharmaceuticals Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Emcure Pharmaceuticals Ltd. from all sources in a single place.

Load latest

Emcure Pharmaceuticals Ltd.

07 Aug 2025

1317.00

-1.90%

Result

Emcure Pharmaceuticals Ltd - 544210 - Outcome Of The Board Meeting Held On August 07, 2025 …

BSE India

Outcome of the Board Meeting held on August 07, 2025 to approve the Unaudited Financial Results (Consolidated and Standalone) for the quarter ended June 30, 2025

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	2104.23	2120.70	1838.58	-0.8%	14.4%
Operating Profit Qtr	416.77	402.40	336.32	3.6%	23.9%
Net Profit Qtr	206.95	188.96	144.08	9.5%	43.6%
Earning Per Share Adjusted latest Qtr	10.92	9.97	7.60	9.5%	43.7%

* Consolidated data

Detailed Results

Emcure Pharmaceuticals Ltd.

07 Aug 2025

1317.00

-1.90%

Board Meeting

Emcure Pharmaceuticals Ltd - 544210 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

Outcome of Board Meeting held on August 07, 2025 to approve the Unaudited Financial Results (Consolidated and Standalone) for the quarter ended June 30, 2025

pdf

Emcure Pharmaceuticals Ltd.

04 Aug 2025

1317.00

-1.90%

Emcure Pharma shares gain as JM Financial initiates coverage; check target

Business Standard

JM Financial initiated coverage on Emcure Pharma with a 'Buy' rating and a target price of 1,740, citing its growth prospects

Emcure Pharmaceuticals Ltd. is trading below its 30 day SMA of 1401.0

Emcure Pharmaceuticals Ltd.

03 Aug 2025

1317.00

-1.90%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Newspaper Advertisement of Notice of the 44th Annual General Meeting and e-voting information.

pdf

Emcure Pharmaceuticals Ltd.

02 Aug 2025

1317.00

-1.90%

AGM

Emcure Pharmaceuticals Ltd - 544210 - Intimation Of Notice Of The 44Th Annual General Meeting Of …

BSE India

Intimation of Notice of the 44th Annual General Meeting of Emcure Pharmaceuticals Limited to be held on Thursday, August 28, 2025

pdf

Emcure Pharmaceuticals Ltd.

02 Aug 2025

1317.00

-1.90%

Corp. Note

Emcure Pharmaceuticals Ltd - 544210 - Reg. 34 (1) Annual Report.

BSE India

Annual Report for the Financial Year 2024-25 and the Notice of the 44th Annual General Meeting of Emcure Pharmaceuticals Limited

pdf

Emcure Pharmaceuticals Ltd.

01 Aug 2025

1317.00

-1.90%

Corp. Action

Emcure Pharmaceuticals Ltd - 544210 - Intimation Of The 44Th AGM And Record Date For Final …

BSE India

Intimation of the 44th AGM and Record date for Final Dividend for the financial year ended March 31, 2025.

pdf

Emcure Pharmaceuticals Ltd.

28 Jul 2025

1317.00

-1.90%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Intimation for Earnings Call - Q1 FY26

pdf

Emcure Pharmaceuticals Ltd.

28 Jul 2025

1317.00

-1.90%

Board Meeting

Emcure Pharmaceuticals Ltd - 544210 - Board Meeting Intimation for Approval Of Unaudited Financial Results (Standalone …

BSE India

Emcure Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 ,inter alia, to consider and approve unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2025.

pdf

Emcure Pharmaceuticals Ltd.

17 Jul 2025

1317.00

-1.90%

Emcure Pharma, Sanofi India shares edge higher; what's behind the move?

Business Standard

Emcure Pharma stock was quoting at 1,382.5, up 1.5 per cent from the previous day's close of 1,362.5 as the company announced a distribution and promotion partnership with Sanofi India

Emcure Pharmaceuticals Ltd. is trading above its 200 day SMA of 1245.3

Emcure Pharmaceuticals to distribute Sanofi's oral anti-diabetic drugs

Business Line | 16 Jul 2025